Lyndsey Young
Executive Director, Quality Tr1x therapeutics
Seminars
Thursday 17th September 2026
Building High-Impact Vendor Partnerships to Accelerate Cell Therapy Execution
2:10 pm
- Building phase-appropriate quality systems with defined quality indicators to enable earlystage cell therapy development
- Embedding quality indicators into vendor selection and supplier partnerships to protect execution
- Leveraging quality indicators as strategic tools for risk management and operational agility
